Having trouble accessing articles? Reset your cache.

PNT2258: Phase I started

ProNAi began a single-arm, open-label, dose-escalation, U.S. Phase I trial to evaluate

Read the full 128 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE